Cargando…
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Immunotherapy, where the patient's own immune system is exploited to eliminate tumor cells, has become one of the most prominent new cancer treatment options in the last decade. The main hurdle for classical cancer vaccines is the need to identify tumor- and patient specific antigens to include...
Autores principales: | Locy, Hanne, de Mey, Sven, de Mey, Wout, De Ridder, Mark, Thielemans, Kris, Maenhout, Sarah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297829/ https://www.ncbi.nlm.nih.gov/pubmed/30619273 http://dx.doi.org/10.3389/fimmu.2018.02909 |
Ejemplares similares
-
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8(+) T cells
por: de Mey, Wout, et al.
Publicado: (2023) -
The tumor micro-environment in pediatric glioma: friend or foe?
por: Messiaen, Julie, et al.
Publicado: (2023) -
Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends
por: Gargiulo, Ernesto, et al.
Publicado: (2019) -
A synthetic DNA template for fast manufacturing of versatile single epitope mRNA
por: de Mey, Wout, et al.
Publicado: (2022) -
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
por: De Mey, Wout, et al.
Publicado: (2022)